FDA Inspection
Viatris Inc.Viatris Inc. – FDA Inspection, Aug 25, 2017
Record Details
This FDA Inspection record concerns Viatris Inc., with an inspection on August 25, 2017, issued by the Baltimore District Office, covering human drugs.
- People
- Kshitij A. Patkar (Investigator)
- Nancy M. Espinal (FDA Associated Person)
- Rebecca E. Dowd (FDA Associated Person)
- Sneha S. Patel (Issuing Officer)
View Company Profile
ID · f57ac413-bf74-4ecc-a362-875550cdb110
Inspection Facts
- Inspection number
- 1024011
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Viatris Inc.
21| Date | Classification | Office | Project area |
|---|---|---|---|
| August 28, 2026 | Not classified | Baltimore District Office | |
| April 28, 2026 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 18, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 26, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 15, 2019 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
Other documents for Viatris Inc.
- FDA Inspection 1302530 - 2026-08-28
- FDA Inspection 1311680 - 2026-04-28
- FDA Inspection 1219018 - 2023-08-18
- FDA Inspection 1170444 - 2022-05-26
- FDA Inspection 1099590 - 2019-08-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.